臨床試驗

IonMAN II Trial- Early Feasibility Study of the IoNIR Ridaforolimus-Eluting Coronary Stent System

NCT：NCT06071702 · SUSPENDED

NCT IDNCT06071702

狀態SUSPENDED

開始日期2025-08-07

完成時間2026-12-07

SponsorMedinol Ltd. (INDUSTRY)

First posted2023-10-06

Last updated2026-10-09

簡要摘要

This is a prospective, multi-center, single-arm, open-label, early feasibility study to provide preliminary evidence for the safety and efficacy of the novel IoNIR stent system

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。